Verge HealthTech Fund
VC Fund
Singapore, Singapore
Verge HealthTech Fund is a VC fund in Singapore focused on Health Care and Medical. We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging AsiaWe believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might notscale, or find the best world-changing application. This is where we can help.
- Total investments:
- 30
- Last investment:
- Lead investor:
- 57%
- Fund size:
- $250k
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Verge HealthTech Fund invests in
Stages Verge HealthTech Fund invests in
Countries Verge HealthTech Fund invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $500k–$4.7M
- Pre-Seed
- $520k–$1M
Investment Focus
Industry
- Health Care 18 (60%)
- Medical 6 (20%)
- Medical Device 6 (20%)
- Artificial Intelligence 5 (17%)
- Software 4 (13%)
Stage
- Seed 17 (57%)
- Pre-Seed 3 (10%)
- Series A 2 (7%)
- Venture - Series Unknown 2 (7%)
- Funding Round 1 (3%)
Country
- Estonia 3 (10%)
- Singapore 3 (10%)
- United States 3 (10%)
- United Kingdom 3 (10%)
- Canada 2 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ferdinand Hui
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
Joseph Mocanu
Managing Partner
|
Managing Partner | Total investments: 4 | Find email | |
Rupam Shrivastava
Advisor
|
Advisor | Total investments: 3 | Find email | |
Scarlett Chen
Managing Partner
|
Managing Partner | Total investments: 3 | Find email | |
Sigvards Krongorns
Associate
|
Associate | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
THINKMD
|
THINKMD develops next-generation clinical assessment and data analytics platforms that transform point-of-care medicine by putting medically validated clinical assessment capability into the hands of non-healthcare professionals. This technology allows for the decentralization of healthcare delivery into communities and homes by pairing clinicalknowledge and Bayesian/pattern recognition algorithms with simple to use mobile technology. Its goal is to reinvent the healthcare delivery paradigm, reduce costs, and improve outcomes by improving healthcare access and care-seeking behavior while building a public health knowledge database. | Venture - Series Unknown / Aug 12, 2026 | |
Neuraworx Medical Technology
|
Neuraworx Medical Technology is a neurotechnology company developing first-in-class bioelectronic solutions for brain health. | Seed / Dec 18, 2025 | |
Understanding Zoe
|
Understanding Zoe is a neuroaffirming application that turns every report and observation into an actionable step for a better connect. | $499.3K / Seed / Nov 06, 2025 | |
Zoundream
|
Babies cry sounds convey a massive stream of information: its needs, emotions, well-being, and physical status. Indeed, it’s the only way small babies have to communicate with the external world.In Zoundream, we use cutting edge developments in sound recognition, to the specific field of baby cries. Our technology can not only translate cries inreal time (e.g. hungry, sleepy), but also identify potential pathologies – improving well-being of families and babies, all around the world. | $4.7M / Seed / Sep 26, 2025 | |
Lifeyear
|
Lifeyear is a healthtech startup focused on transforming cardiovascular care with next-generation remote patient management. | $1.5M / Seed / Jun 24, 2025 | |
Prosoma
|
Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life. | Series A / Jun 16, 2025 | |
CareLoop Health
|
CareLoop, an innovation emerging from the University of Manchester, furnishes patients with digital support resources while simultaneously providing healthcare professionals with the means to monitor and track patient symptoms. | $2.2M / Seed / Jan 30, 2025 | |
|
Prosoma
|
Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life. | $4.6M / Seed / Jan 20, 2025 | |
HELLO INSIDE
|
HELLO INSIDE is a scientific self care company empowering people to have data-driven conversations with their bodies so everybody can unlock their best self. Our mission is to lead a new self care movement that’s data driven, truly personalized and rooted in science by building the world's leading scientific self care company. HELLO INSIDEstarts by using continuous glucose monitors to help people better understand different challenges in life as their body and health needs evolve.We at HELLO INSIDE are committed to creating a healthier and happier future for people and communities through the power of scientific self care. | $1.8M / Seed / Sep 09, 2024 | |
|
HELLO INSIDE
|
HELLO INSIDE is a scientific self care company empowering people to have data-driven conversations with their bodies so everybody can unlock their best self. Our mission is to lead a new self care movement that’s data driven, truly personalized and rooted in science by building the world's leading scientific self care company. HELLO INSIDEstarts by using continuous glucose monitors to help people better understand different challenges in life as their body and health needs evolve.We at HELLO INSIDE are committed to creating a healthier and happier future for people and communities through the power of scientific self care. | $1.8M / Seed / Sep 09, 2024 | |
| See all 30 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Verge HealthTech Fund invest in?
Verge HealthTech Fund invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Pre-Seed stage. Most of the 30 investments tracked by Shizune back companies in Estonia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Verge HealthTech Fund's check size?
Verge HealthTech Fund typically joins rounds of $500k–$4.7M at Seed and $520k–$1M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Verge HealthTech Fund participates in.
How do I contact Verge HealthTech Fund?
Public channels for Verge HealthTech Fund include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Verge HealthTech Fund?
The team at Verge HealthTech Fund includes Ferdinand Hui (Venture Partner), Joseph Mocanu (Managing Partner) and Rupam Shrivastava (Advisor). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
